These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 14923903)
1. Lysergic acid diethylamide; a clinical-psychological study. SAVAGE C Am J Psychiatry; 1952 Jun; 108(12):896-900. PubMed ID: 14923903 [No Abstract] [Full Text] [Related]
2. Clinical reactions and tolerance to LSD in chronic schizophrenia. CHOLDEN LS; KURLAND A; SAVAGE C J Nerv Ment Dis; 1955 Sep; 122(3):211-21. PubMed ID: 13295823 [No Abstract] [Full Text] [Related]
3. The therapeutic value of lysergic acid diethylamide in mental illness. SANDISON RA; SPENCER AM; WHITELAW JD J Ment Sci; 1954 Apr; 100(419):491-507. PubMed ID: 13175011 [No Abstract] [Full Text] [Related]
4. Prevention of psychological effects of d-lysergic acid diethylamide (LSD 25) by its 2-brom derivative (BOL 148). GINZEL KH; MAYER-GROSS W Nature; 1956 Jul; 178(4526):210. PubMed ID: 13348662 [No Abstract] [Full Text] [Related]
5. [Effects of diethylamide of lysergic acid on the psychic symptoms of schizophrenia; psychopathological study]. CALLIERI B; RAVETTA M Rass Studi Psichiatr; 1955; 44(1):39-88. PubMed ID: 13246040 [No Abstract] [Full Text] [Related]
6. [Psychophysical correlations. VIII. Experimental tests in schizophrenia; lysergic acid diethylamide and mescaline]. FISCHER R; GEORGI F; WEBER R Schweiz Med Wochenschr; 1951 Sep; 81(35):837-40. PubMed ID: 14866109 [No Abstract] [Full Text] [Related]
7. [Electrical rhythms of the brain following administration of mescaline and lysergic acid (LSD 25) in mental disorders]. SANGUINETI I; NEGRI VU; LARICCHIA R Riv Sper Freniatr Med Leg Alien Ment; 1955 Dec; 79(4):771-97. PubMed ID: 13311367 [No Abstract] [Full Text] [Related]
8. [Psychophysical correlations. VIII. Experimental tests in schizophrenia: lysergic acid diethylamide and mescaline]. FISCHER R; GEORGI F; WEBER R Schweiz Med Wochenschr; 1951 Aug; 81(34):817-9; contd. PubMed ID: 14866104 [No Abstract] [Full Text] [Related]
10. Intoxicant drugs (mescaline and lysergic acid diethylamide) in psychotherapy. FREDERKING W J Nerv Ment Dis; 1955 Mar; 121(3):262-6. PubMed ID: 14381913 [No Abstract] [Full Text] [Related]
11. Psychological aspects of the LSD treatment of the neuroses. SANDISON RA J Ment Sci; 1954 Apr; 100(419):508-15. PubMed ID: 13175012 [No Abstract] [Full Text] [Related]
12. Effects of mescaline and lysergic acid (d-LSD-25). HOCH PH; CATTELL JP; PENNES HH Am J Psychiatry; 1952 Feb; 108(8):579-84. PubMed ID: 14903183 [No Abstract] [Full Text] [Related]
14. [Experiences with the use of alkanolamides of lysergic acid in clinical obstetrics]. WOLLMANN H Z Geburtshilfe Gynakol; 1950; 134(1):109-23. PubMed ID: 14810077 [No Abstract] [Full Text] [Related]
15. [First trials of psychopharmacological antagonism; experimental psychoses induced with d-lysergic acid diethylamide and treated with chlorpromazine and reserpine]. GIBERTI F; GREGORETTI L Sist Nerv; 1955; 7(4):301-10. PubMed ID: 13290891 [No Abstract] [Full Text] [Related]
16. Psychophysiological investigations in experimental psychoses; results of the exhibition of d-lysergic acid diethylamide to psychiatric patients. SLOANE B; DOUST JW J Ment Sci; 1954 Jan; 100(418):129-44. PubMed ID: 13152528 [No Abstract] [Full Text] [Related]
17. The fluorometric determination of lysergic acid diethylamide and ergonovine. BOYD ES Arch Int Pharmacodyn Ther; 1958 May; 115(1-2):43-51. PubMed ID: 13545885 [No Abstract] [Full Text] [Related]
18. Clinical reactions of schizophrenics to sodium amytal, pervitin hydrochloride, mescaline sulfate, and d-lysergic acid diethylamide (LSD25). PENNES HH J Nerv Ment Dis; 1954 Feb; 119(2):95-112. PubMed ID: 13163687 [No Abstract] [Full Text] [Related]